LIFECORE BIOMEDICAL, INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
LIFECORE BIOMEDICAL, INC. (LFCR) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$135.00 thousand for the 9-month period ending 2020-02-23, per its 10-Q filed 2020-04-03.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2020-04-03
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2020-02-23 was -$150.00K, a 700.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2019-11-24 was $8.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2019-08-25 was $7.00K, a 133.33% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2019-05-26 was -$212.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2019 was -$188.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2018 was -$157.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2017 was -$586.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2016 was -$46.00K, a 151.11% decline from fiscal 2015.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2020-02-23 | -$150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | -$142.00K derived: sum of 2 quarters · filed 2020-04-03 | -$135.00K 10-Q · filed 2020-04-03 | -$347.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2019-11-24 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | $15.00K 10-Q · filed 2020-01-02 | -$197.00K derived: sum of 3 quarters · filed 2020-01-02 | -$172.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2019-08-25 | $7.00K 10-Q · filed 2019-10-03 | -$205.00K derived: sum of 2 quarters · filed 2019-10-03 | -$180.00K derived: sum of 3 quarters · filed 2020-04-03 | -$184.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2019-05-26 | -$212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | -$187.00K derived: sum of 2 quarters · filed 2020-04-03 | -$191.00K derived: sum of 3 quarters · filed 2020-04-03 | -$188.00K 10-K · filed 2019-08-01 |
| 2019-02-24 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $21.00K derived: sum of 2 quarters · filed 2020-04-03 | $24.00K 10-Q · filed 2020-04-03 | -$40.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-11-25 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | -$1.00K 10-Q · filed 2020-01-02 | -$65.00K derived: sum of 3 quarters · filed 2020-01-02 | -$203.00K derived: sum of 4 quarters · filed 2020-01-02 |
| 2018-08-26 | $3.00K 10-Q · filed 2019-10-03 | -$61.00K derived: sum of 2 quarters · filed 2019-10-03 | -$199.00K derived: sum of 3 quarters · filed 2019-10-03 | -$156.00K derived: sum of 4 quarters · filed 2019-10-03 |
| 2018-05-27 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | -$202.00K derived: sum of 2 quarters · filed 2019-08-01 | -$159.00K derived: sum of 3 quarters · filed 2019-08-01 | -$157.00K 10-K · filed 2019-08-01 |
| 2018-02-25 | -$138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | -$95.00K derived: sum of 2 quarters · filed 2019-04-04 | -$93.00K 10-Q · filed 2019-04-04 | -$415.00K derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-11-26 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $45.00K 10-Q · filed 2019-01-07 | -$277.00K derived: sum of 3 quarters · filed 2019-08-01 | -$484.00K derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-08-27 | $2.00K 10-Q · filed 2018-10-05 | -$320.00K derived: sum of 2 quarters · filed 2019-08-01 | -$527.00K derived: sum of 3 quarters · filed 2019-08-01 | -$588.00K derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-05-28 | -$322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | -$529.00K derived: sum of 2 quarters · filed 2019-08-01 | -$590.00K derived: sum of 3 quarters · filed 2019-08-01 | -$586.00K 10-K · filed 2019-08-01 |
| 2017-02-26 | -$207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | -$268.00K derived: sum of 2 quarters · filed 2018-04-05 | -$264.00K 10-Q · filed 2018-04-05 | -$330.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2016-11-27 | -$61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | -$57.00K 10-Q · filed 2018-01-05 | -$123.00K derived: sum of 3 quarters · filed 2018-08-09 | |
| 2016-08-28 | $4.00K 10-Q · filed 2017-09-28 | -$62.00K derived: sum of 2 quarters · filed 2018-08-09 | ||
| 2016-05-29 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | -$46.00K 10-K · filed 2018-08-09 | ||
| 2016-02-28 | $20.00K 10-Q · filed 2017-04-07 | |||
| 2015-08-30 | $3.00K 10-Q · filed 2016-09-29 | $40.00K derived: sum of 2 quarters · filed 2018-03-15 | ||
| 2015-05-31 | $37.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $90.00K 10-K/A · filed 2018-03-15 | ||
| 2015-03-01 | $53.00K 10-Q · filed 2016-03-30 | |||
| 2014-05-25 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | -$205.00K derived: sum of 2 quarters · filed 2016-08-01 | -$283.00K derived: sum of 3 quarters · filed 2016-08-01 | -$329.00K 10-K · filed 2016-08-01 |
| 2014-02-23 | -$206.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$284.00K derived: sum of 2 quarters · filed 2015-04-02 | -$330.00K 10-Q · filed 2015-04-02 | -$367.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-11-24 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$124.00K 10-Q · filed 2015-01-09 | -$161.00K derived: sum of 3 quarters · filed 2015-07-31 | -$161.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-08-25 | -$46.00K 10-Q · filed 2014-10-08 | -$83.00K derived: sum of 2 quarters · filed 2015-07-31 | -$83.00K derived: sum of 3 quarters · filed 2015-07-31 | -$83.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-05-26 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | -$37.00K derived: sum of 2 quarters · filed 2015-07-31 | -$37.00K derived: sum of 3 quarters · filed 2015-07-31 | -$217.00K 10-K · filed 2015-07-31 |
| 2013-02-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | -$180.00K 10-Q · filed 2014-03-28 | |
| 2012-11-25 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | -$180.00K 10-Q · filed 2014-01-03 | ||
| 2012-08-26 | -$180.00K 10-Q · filed 2013-09-26 | |||
| 2012-05-27 | -$12.00K 10-K · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |